Spyre Therapeutics <SYRE.O>: Deutsche Bank cuts target price to $127 from $135
SYRE•Related News
Spruce Biosciences launches site for planned TA-ERT Sanfilippo B confirmatory trial in Q4 2026
SPRB•
Kohl's misses sales estimates on cautious discretionary spending
KSS•
FOREX-Dollar nudges higher ahead of US inflation data; Aussie gains on rate bets
SPY•
Figma Chief Accounting Officer Herb Tyler disposes of 1,840 common shares worth $49,937.6
FIG•
Oportun updates executive severance, change-in-control policy with 150% target bonus payout for CEO
OPRT•